DM
VTYX

Deerfield Management’s Ventyx Biosciences VTYX Stock Holding History

Deerfield Management’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-534,737
Closed -$1.17M – 145
2024
Q4 		$1.17M Sell
534,737
-6,180,764
-92% -$14M 0.02% 79
2024
Q3 		$14.6M Buy
6,715,501
+885,931
+15% +$2.04M 0.22% 60
2024
Q2 		$13.5M Buy
5,829,570
+2,287,570
+65% +$9.5M 0.22% 59
2024
Q1 		$19.5M Buy
+3,542,000
New +$16.2M 0.34% 53
2023
Q3 		– Sell
-617,000
Closed -$20.2M – 106
2023
Q2 		$20.2M Hold
617,000
– – 0.43% 48
2023
Q1 		$20.7M Buy
+617,000
New +$24M 0.46% 52

Other funds holding VTYX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deerfield Management's VTYX Position: Q1 2025 in Review

Deerfield Management sold out of Ventyx Biosciences (VTYX) in Q1 2025, closing a stake of 534,737 shares — an estimated $1.17M sold.

Deerfield Management first reported a position in VTYX in Q1 2023 and held it in 6 quarters. The position peaked at $20.7M in Q1 2023. 116 funds tracked by Wall St. Rank hold VTYX as of Q1 2025.

  • Deerfield Management reported no remaining Ventyx Biosciences position as of Q1 2025 after selling out during the quarter.
  • Deerfield Management sold 534,737 Ventyx Biosciences shares in Q1 2025, an estimated $1.17M.
  • Deerfield Management first reported a position in Ventyx Biosciences in Q1 2023 and held it in 6 quarters.
  • Deerfield Management's Ventyx Biosciences position peaked at $20.7M in Q1 2023.
  • 116 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2025.

Based on Deerfield Management's 13F filing for Q1 2025, filed 15 May 2025.